© EQS Newswire
09.05.2025
SOON
LISTED
SIX
Sonova erzielt Marktanteilsgewinne in allen Geschäftsbereichen und kündigt bevorstehenden CEO-Wechsel an
News Preview
Group Media & Investor ReleaseAd hoc-Mitteilung gemäss Art. 53 KR
Stäfa (Schweiz), 9. Mai 2025 – Die Sonova Holding AG (SWX: SOON), ein führender Anbieter innovativer Hörlösungen, gibt heute das Ergebnis für das Geschäftsjahr 2024/25 bekannt. Mit Marktanteilsgewinnen in allen vier Geschäftsbereichen im zweiten Geschäftshalbjahr erzielte die Gru......
Themefolio
Profiler
Peergroup
© EQS Newswire
09.05.2025
SOON
LISTED
SIX
Sonova achieves market share gains across all businesses and announces upcoming CEO transition
News Preview
Group Media & Investor ReleaseAd hoc announcement pursuant to Art. 53 LR
Staefa (Switzerland), May 9, 2025 – Sonova Holding AG (SWX: SOON), a leading provider of innovative hearing solutions, today announces results for the 2024/25 financial year. With market share gains across all four businesses in the second half, Group sales reached CHF 3,8......
Themefolio
Profiler
Peergroup
© Globe Newswire
09.05.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Interim Results for the First Three Months of 2025
News Preview
COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2025....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
09.05.2025
ZEAL
LISTED
CPH
Zealand Pharma announces closing of collaboration and license agreement with Roche
News Preview
Company announcement – No. 12 / 2025...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
08.05.2025
VITR
LISTED
STO
Vitrolife AB (publ) becomes lead investor in AutoIVF
News Preview
GOTHENBURG, Sweden, May 8, 2025 /PRNewswire/ -- The Vitrolife Group today announces it has become a leading investor in AutoIVF. This strategic investment aligns with our corporate strategy of improving affordability and access to IVF to patients around the world.
AutoIVF, is an early-stage MedTech company with the aim to make IVF more accessibl...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
GMAB
LISTED
CPH
Genmab Announces Financial Results for the First Quarter of 2024
News Preview
May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
BIOA B
LISTED
STO
Exidavnemab phase 2a study expanded to include MSA patients
News Preview
STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System Atrophy (MSA) patients for treatment with the alpha-synuclein antibody exidavnemab in the ongoing EXIST Phase 2a study.
The Phase 2a study EXIST (EXIda...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
HELP
LISTED
NASDAQ
Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that the United States Patent and Trademark Office has granted U.S. patent 12,29...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
DFTX
LISTED
NASDAQ
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its first quarter 2025 financial results and provided an update on business highlights.
“We are proud to share that all three of our pivotal...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
ORY
LISTED
BME
ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
News Preview
MADRID and CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today the publication of the Spanish provisional resolution proposal for Med4Cure, the first Important Project of Common European Interest (I...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the first quarter of 2025, along with recent product highlights and corporate updates.
“In the first quarter, we continued to advance both our global pipeline and commercial business,” said Dr. Samantha Du, Founder, Chairperson, and CEO of Zai Lab. “We are rapidly ex...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
SOBI
LISTED
STO
Bulletin from Sobi's Annual General Meeting (AGM)
News Preview
STOCKHOLM, May 8, 2025 /PRNewswire/ -- The Swedish Orphan Biovitrum AB (publ) (Sobi®) AGM was convened today on 8 May 2025. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows:
Adoption of the profit and loss statements and balance sheet and discharge of liability
The AGM adopted the income statements a...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
08.05.2025
SOBI
LISTED
STO
Bulletin from Sobi's Annual General Meeting (AGM)
News Preview
STOCKHOLM, May 8, 2025 /PRNewswire/ -- The Swedish Orphan Biovitrum AB (publ) (Sobi®) AGM was convened today on 8 May 2025. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows:
Adoption of the profit and loss statements and balance sheet and discharge of liability
The AGM adopted the income statements a...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
REC
LISTED
EURONEXT
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%
News Preview
Milan, 8th May 2025 – The Board of Directors of Recordati S.p.A. approved the Group’s Interim Report as of 31st March 2025, representing additional voluntary financial reporting(7). The Report was prepared using the assessment, measurement and recognition criteria prescribed by international accounting standards (IFRS). The financial statements as...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
NSIS B
LISTED
CPH
Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook
News Preview
COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The company maintains the full-year outlook....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
NSIS B
LISTED
CPH
Interim report Q1 2025
News Preview
Strong start to the year and confirmed full-year outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
ZEAL
LISTED
CPH
Zealand Pharma Announces Financial Results for the First Three Months of 2025
News Preview
Company announcement – No. 11 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
EHAB
LISTED
NYSE
Enhabit Reports First Quarter 2025 Financial Results
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025.
“Enhabit’s first quarter 2025 results are a product of steadfast execution of our strategies,” said Barb Jacobsmeyer, president and CEO of Enhabit. “Home health census grew 3.7% sequenti...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
CYRX
LISTED
NASDAQ
Cryoport Reports First Quarter 2025 Financial Results
News Preview
Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over yearQ1 2025 revenue from continuing operations of $41.0 million, up 10% year over yearSupporting 711 global clinical trials as of March 31, 2025Strategic partnership with DHL; CRYOPDP divestiture expected to close Q2/Q3 2025NASHVILLE, Tenn., May 7, 2025 /PRNewswire/ -- C...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
CHEMM
LISTED
CPH
Continued growth in revenue and operating profit
News Preview
Trading statement for Q3 2024/25 (1 January - 31 March 2025)...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Wechsel an Vorstandsspitze der Carl Zeiss Meditec AG
News Preview
Wechsel an Vorstandsspitze der Carl Zeiss Meditec AG
Der Vorstandsvorsitzende Dr. Markus Weber scheidet auf eigenen Wunsch und im besten Einvernehmen mit Ablauf des 31.05.2025 aus dem Vorstand aus.
Neuer Vorstandsvorsitzender wird Maximilian Foerst mit Wirkung zum 01.06.2025, derzeit Head of ZEISS Greater China.
Jena, Deutschlan......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Change of President and CEO at Carl Zeiss Meditec AG
News Preview
Change of President and CEO at Carl Zeiss Meditec AG
The President and CEO, Dr. Markus Weber, will step down from the Management Board, of his own accord and on the best of terms, on 31 May 2025.
Starting 1 June 2025, the new President and CEO will be Maximilian Foerst, who is currently Head of ZEISS Greater China.
Jena, Germany | 7 May 2025 | C......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Change of President and CEO at Carl Zeiss Meditec AG
News Preview
Change of President and CEO at Carl Zeiss Meditec AG
Jena, May 7, 2025
The supervisory board of Carl Zeiss Meditec AG (ISIN: DE0005313704) in today’s meeting has agreed on a change in the Management Board of the company. Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG since January 1, 2022, will turn over his position to Maxi......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG
News Preview
Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG
Jena, 7. Mai 2025
Der Aufsichtsrat der Carl Zeiss Meditec AG (ISIN: DE0005313704) hat in seiner heutigen Sitzung eine Veränderung im Vorstand des Unternehmens beschlossen. Dr. Markus Weber, der seit 1. Januar 2022 Vorstandsvorsitzender der Gesellschaft ist, wird sein Amt zum 31. Mai 20......
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 May 2025 at 17.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
ICLR
LISTED
NASDAQ
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities.
Multi-indication studi...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
SN
LISTED
LSE
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*
News Preview
The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
OGI
LISTED
NASDAQ
Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
LIVN
LISTED
NASDAQ
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-year 2025 guidance.
Financial Summary and Highlights(1)
First-quarter revenue of $316.9 million increased 7.4% on a reported basis, 8.9% on a constant-currency basis, and 10.4% on an organi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
LIVN
LISTED
NASDAQ
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced 12-month, top-line data from its OSPREY randomized controlled trial (RCT), evaluating outcomes with the aura6000™ System for the treatment of moderate to severe obstructive sleep apnea (OSA). At 12 months of therapy, the treatment arm responder rate was 65% w...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
CELC
LISTED
NASDAQ
Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call
News Preview
MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the first quarter 2025 after the market closes on Wednesday, May 14, 2025. Management will host a webcast/telecon...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
IMCR
LISTED
NASDAQ
Immunocore reports first quarter financial results and provides a business update
News Preview
Immunocore reports first quarter financial results and provides a business update...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
FYB
LISTED
XETR
Formycon lädt zur Telefonkonferenz zu den Ergebnissen des ersten Quartals 2025 ein und gibt Teilnahme an internationalen Investorenkonferenzen bekannt
News Preview
Pressemitteilung // 07. Mai 2025
Formycon lädt zur Telefonkonferenz zu den Ergebnissen des ersten Quartals 2025 ein und gibt Teilnahme an internationalen Investorenkonferenzen bekannt
Planegg-Martinsried – Die Formycon AG (FWB: FYB, Prime Standard, „Formycon“) plant am 12. Mai die Ergebnisse des ersten Quartals 2025 zu veröffentlichen. Der Vor......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
FYB
LISTED
XETR
Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
News Preview
Presse Release // May 7, 2025Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
Planegg-Martinsried, Germany – Formycon AG (FSB: FYB, Prime Standard, „Formycon“) plans to publish its results for the first quarter of 2025 on May 12, 2025. The Management......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
EVT
LISTED
XETR
Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
News Preview
Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.
The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.
......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
EVT
LISTED
XETR
Evotec erhält Fördergelder in Höhe von 2,5 Mio. USD für die Entwicklung von Tuberkulose-Therapien der nächsten Generation
News Preview
Die Gates Foundation unterstützt Evotec mit einem Zuschuss von 2,5 Mio. USD zur Generierung entscheidender Daten für die Entwicklung neuer Kombinationstherapien gegen Tuberkulose
Die Kooperation setzt die erfolgreiche Partnerschaft zur Bewertung neuer Therapieansätze fort, die auf eine Verkürzung der Behandlungsdauer und die Überwindung......
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition presents data validating novel clinical scale in PBC at EASL 2025
News Preview
STOCKHOLM, SWEDEN – May 7, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will attend the EASL Congress 2025 in Amsterdam, May 7–10, to present validation and implementation data for the newly developed clinical scale for Primary Biliary Cholangitis, PBC.Umecrine Cognition is d...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.05.2025
EVT
LISTED
XETR
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
News Preview
Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies. HAMBURG, DE / ACCESS N...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
TEM
LISTED
NASDAQ
Tempus Reports First Quarter 2025 Results
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2025.
Revenue increased 75.4% year-over-year to $255.7 million in the first quarter of 2025
Quarterly gross profit increased 99.8% year-over-year, reachi...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.05.2025
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS6 May 2025 at 18.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
ERF
LISTED
EURONEXT
Eurofins Sustainability Services Introduces First Recycled Plastics Testing That Leverages Properties of Plastics for Accurate Results to Support Authenticity of Textile Claims
News Preview
Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include recycled plastics testing for the textile, apparel, and footwear industries. By using the most advanced methodology, this is the first service of its kind that can accurately v...
Themefolio
Profiler
Peergroup
© PR Newswire
06.05.2025
ATNM
LISTED
XASE
Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center
News Preview
- Initial clinical data expected in the second half of 2025 from this first-of-its-kind trial to administer a targeted radiotherapy conditioning agent with a commercial CAR-T therapy
- Iomab-ACT supported by results of NIH funded trial with MSK showing effective lymphodepletion of targeted immune cells resulting in negligible rates of...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.05.2025
1SXP
LISTED
XETR
SCHOTT Pharma und Serum Institute of India begrüßen neuen Partner in Joint Venture in Indien; TPG investiert in SCHOTT Poonawalla
News Preview
SCHOTT Pharma und Serum Institute of India begrüßen neuen Partner in Joint Venture in Indien; TPG investiert in SCHOTT Poonawalla
TPG, eine weltweit führende alternative Investmentgesellschaft, übernimmt 35 % der Anteile an SCHOTT Poonawalla von Serum Institute of India (SII)
SII wird weiterhin eine Minderheitsbeteiligung an dem Unternehmen halte......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.05.2025
1SXP
LISTED
XETR
SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla
News Preview
SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla
TPG, a leading global alternative asset management firm will acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII)
SII will retain a minority stake in the company, with SCHOTT Pharma ......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.05.2025
EVT
LISTED
XETR
Weichenstellung für Wachstum 2025 in schwierigem Marktumfeld
News Preview
Konzernumsatz von 200 Mio. €, im Einklang mit Prognose; Shared R&D mit ähnlichem Trend wie im Jahr 2024; Just - Evotec Biologics mit anhaltender Wachstumsdynamik
Signifikante Fortschritte in der strategischen Partnerschaft mit Bristol Myers Squibb im Bereich gezielter Proteinabbau
Strategie baut auf führender Rolle in Technologi......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.05.2025
EVT
LISTED
XETR
Paving the way for 2025 growth in soft market environment
News Preview
Group revenues of € 200 m, on track towards guidance; Shared R&D with similar trend as 2024; Just – Evotec Biologics with continuing growth momentum
Strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Strategy building on technology and science leadership: Focus on high-growth, high-value segme......
Themefolio
Profiler
Peergroup
© Globe Newswire
06.05.2025
BAVA
LISTED
CPH
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines
News Preview
COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has exercised additional options valued at USD 143.6 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.05.2025
COLO B
LISTED
CPH
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
News Preview
Interim financial results, H1 2024/25...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.05.2025
EVT
LISTED
XETR
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
News Preview
Group revenues of € 200 m, on track towards guidance; Shared R&D with similar trend as 2024; Just - Evotec Biologics with continuing growth momentumStrong progress in strategic protein degradation partnership with Bristol Myers SquibbStrategy building on technology and science leadership: Focus on high-growth, high-value segments, simplif...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
BLUE
LISTED
NASDAQ
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
News Preview
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”), Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and Beacon Parent Holdings, L.P. (“Parent”) announced today that all required regulatory approvals to complete the previously announced acquisition of the Company by Carlyle and SK Capital have been received.
N...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
ANAB
LISTED
NASDAQ
Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update
News Preview
SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the first quarter ended March 31, 2025, and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
IBAB
LISTED
EURONEXT
IBA – ACQUISITION OF OWN SHARES
News Preview
Immediate Release – May 5th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
News Preview
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab...
Themefolio
Profiler
Peergroup
© PR Newswire
05.05.2025
INTEG B
LISTED
STO
Integrum appoints Martin Hillsten as new Chief Executive Officer
News Preview
MÖLNDAL, Sweden, May 5, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Martin Hillsten as the new CEO, effective immediately. He succeeds acting CEO Scott Flora, who will continue to support US marketing activities in an advisory capacity and remain on the company's Board of...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
COLO B
LISTED
CPH
Coloplast A/S CEO Kristian Villumsen steps down as of today
News Preview
Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO....
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
TEM
LISTED
NASDAQ
Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant to aid psychiatrists in generating progress notes. Notetaker, which is available in Tempus Hub, ambiently records patient sessions to generate transcr...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS5 May 2025 at 17:00 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
